Innoviva (INVA) Times Interest Earned (2010 - 2026)
Innoviva (INVA) reported Times Interest Earned of $7.02 for Q1 2026, down 20.2% on a YoY basis from $8.79 in Q1 2025, and down 18.52% quarter-over-quarter from $8.61 in Q3 2025.
Innoviva (INVA) Times Interest Earned (2010 - 2026) Analysis & Trends
Innoviva has reported Times Interest Earned for 17 years, with the latest figure at $7.02 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned fell 20.2% year-over-year to $7.02; the trailing twelve-month figure through Mar 2026 stood at $7.63 (down 3.36% YoY), and the FY2025 full-year result was $9.81, up 30.52% from the prior year.
- Times Interest Earned for Q1 2026 stood at $7.02, down from $8.61 in the prior quarter.
- The five-year high for Times Interest Earned was $19.55 in Q3 2023, with the low at -$2.92 in Q1 2022.
- Historically, Times Interest Earned has averaged $4.57 across 5 years, with a median of $7.02 in 2026.
- Annual changes were most pronounced in 2022 — Times Interest Earned slumped 151.78% — and 2023, when it surged 1992672.48%.
- Innoviva's Times Interest Earned stood at $0.0 in 2022, then surged by 1992672.48% to $19.55 in 2023, then slumped by 61.92% to $7.45 in 2024, then climbed by 15.67% to $8.61 in 2025, then dropped by 18.52% to $7.02 in 2026.
- The last three Times Interest Earned figures came in at $7.02 (Q1 2026), $8.61 (Q3 2025), and $10.45 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -258.33 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 11.79 |
| 10 | Innoviva | 1.69 Bn | 1.08 Bn | 75.83 Mn | 7.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.02 |
| Sep 30, 2025 | 8.61 |
| Jun 30, 2025 | 10.45 |
| Mar 31, 2025 | 8.79 |
| Sep 30, 2024 | 7.45 |
| Jun 30, 2024 | 9.43 |
| Mar 31, 2024 | -1.75 |
| Sep 30, 2023 | 19.55 |
| Jun 30, 2023 | -2.20 |
| Mar 31, 2023 | -2.56 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | -2.52 |
| Mar 31, 2022 | -2.92 |
| Sep 30, 2021 | 19.74 |
| Jun 30, 2021 | 20.35 |
| Mar 31, 2021 | -1.16 |
| Dec 31, 2020 | -1.39 |
| Sep 30, 2020 | 18.34 |
| Jun 30, 2020 | 16.62 |
| Mar 31, 2020 | 16.85 |